Medical ontology learning framework to investigate daytime impairment in insomnia disorder and treatment effects.

BACKGROUND

Specificity challenges frequently arise in medical ontology used for the representation of real-world data, particularly in defining mental health disorders within widely used classification systems such as the International Classification of Diseases (ICD). This study aims to address these challenges by introducing the Disease-Specific Medical Ontology Learning (DiSMOL) framework, designed to generate precise disease representations from clinical physician notes, with a focus on daytime impairment in insomnia disorder.

METHODS

The study applied the Disease-Specific Medical Ontology Learning framework to clinical notes to better represent daytime impairment. The framework's performance was compared to insomnia expert-selected codes from ICD. Key statistical methods included sensitivity and F1-score comparisons, as well as analysis of symptom changes after the use of various medications, including benzodiazepines, non-benzodiazepine receptor agonists, and trazodone.

RESULTS

The DiSMOL framework significantly enhances the identification of daytime impairment in people with insomnia. Sensitivity increases from 17% to 98%, and the F1-score improves from 28% to 86%, compared with expert-selected ICD codes. Additionally, the framework reveals significant increases in daytime impairment symptoms following benzodiazepine use (18.9%), while traditional ICD codes do not detect any significant change.

CONCLUSIONS

The study demonstrates that DiSMOL offers a more accurate method for identifying specific disease aspects, such as daytime impairment in insomnia, than traditional coding systems. These findings highlight the potential of specialized ontologies to enhance the representation and analysis of real-world clinical data, with important implications for healthcare policy and personalized medicine.